A common variant of CDKN2A (p16) predisposes to breast cancer.
about
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL ExpressionAssociation between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessmentPotential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinomaFranklin H. Epstein Lecture. Both ends of the leash--the human links to good dogs with bad genes.The chromosome 9p21.3 coronary heart disease risk allele is associated with altered gene expression in normal heart and vascular tissuesCommon low-penetrance risk variants associated with breast cancer in Polish women.Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.CDKN2A mutations and melanoma risk in the Icelandic population.Risk of second primary cancer in men with breast cancerPrecursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriersHypermethylation of the 5' CpG island of the p14ARF flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression.DNA testing for variants conferring low or moderate increase in the risk of cancer.Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus.Coverage of the genetic background of breast cancer in the polish population.Low-risk Genes and Multi-organ Cancer Risk in the Polish Population.The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil.A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.Malignant melanoma and breast carcinoma: a bidirectional correlation.Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population.The genetics of melanoma
P2860
Q21092443-A8697454-3551-4078-8457-A6BFCBF27430Q33733935-FC5631E1-C0D2-4F51-8990-700230B274FEQ33796155-B3397F2A-BB45-4FA6-9730-8CA27B420873Q33962407-F20124D5-43B3-482B-AF6E-82A9EDA72924Q34294115-37925F78-DF69-4F3B-B634-699187D03A57Q34328195-0EC99E63-4FBC-443D-A9E5-E7BB91A696A6Q34493797-5EAC9A67-9028-4CA6-B88A-B6C5AFC9B600Q34694716-00F1320D-70A2-4756-9A9C-939233D97993Q35558112-5544351E-D819-410D-9D91-5A24924BF209Q35609672-E63A7197-C8FC-41D2-B8B2-486607FA9F8BQ35749402-BFF34535-D0E6-42E9-A24F-320097E8E288Q35846896-60EBB95F-1F97-445D-9B0E-0F45A7315DDEQ36047747-CEDB1229-08D7-4F3A-A3F7-F0512F3F7971Q36316169-16446CEE-6616-4438-874F-CC76FCA8E992Q37327200-99A15E07-DA26-46EC-B3B3-41BE11A08480Q37864570-B71EE8C7-2CE9-488B-9AC8-064EE039E99CQ41839357-BC996E10-80C2-459D-8EF1-DBA707ABD9ECQ42244979-0859FDD4-EAAC-4901-9F4F-4E4214687D0BQ45381658-162A9668-1D5D-4612-9BD6-888B9AB7E3CAQ48146300-8B038CCE-FDB8-4990-BF4B-5D8B15F62469Q51129513-F839A5D8-0100-4389-8480-73B4466B1EE5Q55261258-B782AE98-6397-4870-A50F-22DBD24D21C3Q56437102-592EAD17-E026-4354-93B7-E5A87C45BFCE
P2860
A common variant of CDKN2A (p16) predisposes to breast cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A common variant of CDKN2A (p16) predisposes to breast cancer.
@ast
A common variant of CDKN2A (p16) predisposes to breast cancer.
@en
type
label
A common variant of CDKN2A (p16) predisposes to breast cancer.
@ast
A common variant of CDKN2A (p16) predisposes to breast cancer.
@en
prefLabel
A common variant of CDKN2A (p16) predisposes to breast cancer.
@ast
A common variant of CDKN2A (p16) predisposes to breast cancer.
@en
P2093
P2860
P50
P356
P1476
A common variant of CDKN2A (p16) predisposes to breast cancer.
@en
P2093
Gozdecka-Grodecka S
Gronwald J
Grzybowska E
Huzarski T
Kowalska E
Mackiewicz A
P2860
P304
P356
10.1136/JMG.2005.031476
P407
P577
2005-05-06T00:00:00Z